Molecular diagnostics of human papillomavirus

Laboratory Medicine

Volumn 41, Issue 9, 2010, Pages 523-530

  Arney, Ashley ^a   Bennett, Katie M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cervical cancer; DNA; Genotyping; HPV; PCR; Sexually transmitted disease

Indexed keywords

PROTEIN E6; PROTEIN E7; VIRUS DNA; WART VIRUS VACCINE;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CONDYLOMA ACUMINATUM; DIAGNOSTIC PROCEDURE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; PAPANICOLAOU TEST; PROTEIN ANALYSIS; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS IDENTIFICATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 78349280723     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM75WGJSVMI7VVEF     Document Type: Review

References (48)

1. Genital HPV Infection-CDC Fact Sheet. Centers for Disease Control and Prevention Web site. Available at: www.cdc.gov/STD/HPV/STDFact-HPV.htm. Accessed March 16, 2010.
2. Bruns DE, Burtis CA, Ashwood ER. Fundamentals of Molecular Diagnostics. 1st ed. St. Louis, MO: Saunders Elsevier; 2007.
3. Weinstock H, Berman S, Cates W, Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6-10.
4. McConnell TH. The Nature of Disease: Pathology for the Health Professions. Baltimore, MD: Lippincott Williams & Wilkins; 2007.
5. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122-163.
6. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: Unresolved issues. Nat Rev Cancer. 2007;7:11-22.
7. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324:17-27.
8. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527. (Pubitemid 36159887)
9. Munoz N, Castellsague X, de Gonzalez AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24(suppl 3):S3/1-10.
10. HPV and Cancer. Centers for Disease Control and Prevention Web site. Available at: www.cdc.gov/hpv/cancer.html. Accessed March 16, 2010.
11. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
12. Steenbergen RD, de Wilde J, Wilting SM, et al. HPV-mediated transformation of the anogenital tract. J Clin Virol. 2005;32(suppl 1):S25-S33.
13. Molijn A, Kleter B, Quint W, et al. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol. 2005;32(suppl 1):S43-S51.
14. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
15. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749-1757.
16. The Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests. American Society for Colposcopy and Cervical Pathology Web site. Available at: www.asccp.org/consensus.shtml. Accessed March 16, 2010.
17. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003;127:946-949.
18. Villa LL, Denny, L. Chapter 7: Methods for detection of HPV infection and its clinical utility. International Journal of Gynecology & Obstetrics. 2006;94(suppl 1):S71-S80.
19. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813-819.
20. Brown DR, Schroeder JM, Bryan JT, et al. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol. 1999;37:3316-3322.
21. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer. 2007;121:621-632.
22. Wiley D, Masongsong E. Human papillomavirus: The burden of infection. Obstet Gynecol Surv. 2006;61(suppl 1):S3-S14.
23. Gardasil. Food and Drug Administration Web site. Available at: www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042.htm. Accessed March 18, 2010.
24. Cervarix. Food and Drug Administration Web site. Available at: www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186957.htm. Accessed March 18, 2010.
25. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
26. Vaeteewoottacharn K, Chamutpong S, Ponglikitmongkol M, et al. Differential localization of HPV16 E6 splice products with E6-associated protein. Virol J. 2005;2:50.
27. Malloy C, Sherris, J, Herdman, C. HPV DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-Resource Settings. 2000. Available at: www.path.org/publications/details.php?i=458. Accessed March 16, 2010.
28. Chin-Hong PV, Klausner JD. New diagnostic tests for HPV in the developed and the developing world. MLO Med Lab Obs. 2008;40:48,50,52-53.
29. Women's Health Diagnostic Assays (IVDD). 2007. Available at rochediagnostics.ca/lab/molecular/wh.php#wh2. Accessed March 16, 2010.
30. Jeronimo J, Wentzensen N, Long R, et al. Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software. J Clin Microbiol. 2008;46:2759-2765.
31. INNO-LiPA HPV Genotyping Extra [package insert]. Ghent, Belgium: Innogenetics; 2007.
32. Sandri MT, Lentati P, Benini E, et al. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol. 2006;44:2141-2146.
33. PapilloCheck HPV-Screening Brochure. Available at: www.greinerbioone.com/ UserFiles/File/PailloCheck/Papillo-Laborinfo-074%20046.pdf. Accessed March 16, 2010.
34. Dalstein V, Merlin S, Bali C, et al. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. J Virol Methods. 2009;156:77-83.
35. Multiplex HPV Genotyping Kit for Research in Epidemiology [package insert]. In: Multimetrix, ed. Heidelberg, Germany.
36. Schmitt M, Bravo IG, Snijders PJ, et al. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol. 2006;44:504-512.
37. Clavel C, Masure M, Putaud I, et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol. 1998;51:737-740. (Pubitemid 28480329)
38. hc2 HPV DNA Test [package insert]. Gaithersburg, MD: Digene; 2007.
39. Hybrid Capture 2 High-Risk HPV DNA Test [package insert]. Gaithersburg, MD: Digene; 2007.
40. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: A cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929-936.
41. Lyamichev V, Mast AL, Hall JG, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol. 1999;17:292-296.
42. Invader. 2009. Available at: www.twt.com/invader/invader.html. Accessed March 18, 2010.
43. Ginocchio CC, Barth D, Zhang F. Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the Digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA. J Clin Microbiol. 2008;46:1641-1646.
44. Schutzbank TE, Jarvis C, Kahmann N, et al. Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol. 2007;45:4067-4069.
45. Stillman MJ, Day SP, Schutzbank TE. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus. J Clin Virol. 2009;45(suppl 1):S73-S77.
46. Cuzick J, Mayrand MH, Ronco G, et al. Chapter 10: New dimensions in cervical cancer screening. Vaccine. 2006;24(suppl 3):S3/90-97.
47. Lie AK, Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn. 2008;8:405-415.
48. Stoler MH, Castle PE, Solomon D, et al. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol. 2007;127:335-337.